These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10657541)

  • 1. Affinity of cholecystokinin receptor antagonists for the gastrin-binding protein.
    Rorison KA; Yang Z; Baldwin GS
    Eur J Pharmacol; 2000 Jan; 388(1):9-15. PubMed ID: 10657541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrin and gastrin receptor antagonists bind to both N- and C-terminal halves of the 78 kDa gastrin-binding protein.
    Murphy VJ; Mantamadiotis T; Baldwin GS
    Int J Biochem Cell Biol; 1996 Nov; 28(11):1233-40. PubMed ID: 9022282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein.
    Baldwin GS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7593-7. PubMed ID: 8052625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the preferential binding of actin to the N-terminal hydratase domain of the 78-kDa gastrin-binding protein by non-steroidal anti-inflammatory drugs and gastrin receptor antagonists.
    Baldwin GS
    Biochem Pharmacol; 2001 May; 61(9):1129-36. PubMed ID: 11301046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of progastrin fragments to the 78 kDa gastrin-binding protein.
    Baldwin GS
    FEBS Lett; 1995 Feb; 359(1):97-100. PubMed ID: 7851540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
    Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
    Hahne WF; Jensen RT; Lemp GF; Gardner JD
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines.
    Hoosein NM; Kiener PA; Curry RC; Rovati LC; McGilbra DK; Brattain MG
    Cancer Res; 1988 Dec; 48(24 Pt 1):7179-83. PubMed ID: 3191491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells.
    Magous R; Bali JP
    Regul Pept; 1983 Nov; 7(3):233-41. PubMed ID: 6320314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
    Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN
    Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
    Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.
    Horwell DC; Hughes J; Hunter JC; Pritchard MC; Richardson RS; Roberts E; Woodruff GN
    J Med Chem; 1991 Jan; 34(1):404-14. PubMed ID: 1671419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new inhibitor of mitochondrial fatty acid oxidation.
    Hashimoto T; Shindo Y; Souri M; Baldwin GS
    J Biochem; 1996 Jun; 119(6):1196-201. PubMed ID: 8827458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 70-kDa gastrin-binding protein on DLD-1 human colorectal carcinoma cells.
    Yang CH; Ford J; Karelina Y; Shulkes A; Xiao SD; Baldwin GS
    Int J Biochem Cell Biol; 2001 Nov; 33(11):1071-9. PubMed ID: 11551823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
    Blackmore M; Doherty E; Manning JE; Hirst BH
    Int J Cancer; 1994 May; 57(3):385-91. PubMed ID: 8169000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
    Letari O; Mennuni L; Revel L; Colombo S; Makovec F
    Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.
    Boden PR; Higginbottom M; Hill DR; Horwell DC; Hughes J; Rees DC; Roberts E; Singh L; Suman-Chauhan N; Woodruff GN
    J Med Chem; 1993 Mar; 36(5):552-65. PubMed ID: 7684452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of lysine residues of the 78-kDa gastrin-binding protein reduces gastrin binding.
    Rorison KA; Lee DJ; Baldwin GS
    J Protein Chem; 2001 Jul; 20(5):345-51. PubMed ID: 11732685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites.
    Gaudreau P; Lavigne GJ; Quirion R
    Neuropeptides; 1990 May; 16(1):51-5. PubMed ID: 2174522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.